Andere Sprachen Reneo Pharmaceuticals, Inc.

Aktien

A3CMW7

US75974E1038

RPHM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 22.04.2024			% 5 Tage	% 1. Jan.
1.69 ^USD	-2.87%		+1.81%	+5.62%

28.03.	Reneo Pharmaceuticals, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	RENEO PHARMACEUTICALS, INC. : Ladenburg Thalmann ist neutral	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update	28.03.
North American Morning Briefing : Tech in Focus on -2-	25.03.
Wall Street ouvre stable en l'absence de nouveaux catalyseurs	27.12.
Concentra Biosciences, LLC submitted a non-binding proposal to acquire Reneo Pharmaceuticals, Inc. for $60 million.	26.12.
North American Morning Briefing : Stock Futures -2-	18.12.
Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) added to NASDAQ Biotechnology Index	18.12.
Sector Update: Health Care Stocks Slipping Late Afternoon	14.12.
Top Midday Decliners	14.12.
Sector Update: Health Care Stocks Ease Thursday Afternoon	14.12.
Reneo Pharmaceuticals Says Pivotal Study of Mavodelpar Fails to Meet Primary, Secondary Endpoints; Shares Plunge	14.12.
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	14.12.
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	14.12.
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results	13.11.
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	02.11.
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	02.11.
Women in Stem with Ashley Hall	31.10.23
Reneo Pharmaceuticals, Inc. announces an Equity Buyback for 576,443 shares, for $4.4 million.	30.10.23
Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.	30.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Reneo Pharmaceuticals, Inc.

Aktien

A3CMW7

US75974E1038

RPHM

Andere Sprachen

Filter